Diquafosol
- Generic Name
- Diquafosol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H26N4O23P4
- CAS Number
- 59985-21-6
- Unique Ingredient Identifier
- 7828VC80FJ
- Indication
用于经诊断为伴随泪液异常的角结膜上皮损伤的干眼病患者。
- Associated Conditions
- Dry Eye Syndrome (DES)
- Associated Therapies
- -
Dry Eye Management With 3% Diquafosol Before and After Cataract Surgery
- Conditions
- Dry Eye
- First Posted Date
- 2021-07-07
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Mun Wai Lee
- Target Recruit Count
- 50
- Registration Number
- NCT04952987
- Locations
- 🇲🇾
LEC Eye Centre, Ipoh, Perak, Malaysia
The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT04668118
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath